Page 2 - Robertm Plenge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Carnegie Capital Asset Management LLC reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 18.3% in the second quarter, Holdings Channel reports. The firm owned 97,849 shares of the biopharmaceutical company’s stock after selling 21,956 shares during the period. Carnegie Capital Asset Management LLC’s holdings in Bristol-Myers Squibb were worth $6,257,000 […]

Towercrest Capital Management grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 24.0% in the 2nd quarter, HoldingsChannel reports. The firm owned 5,341 shares of the biopharmaceutical company’s stock after acquiring an additional 1,034 shares during the quarter. Towercrest Capital Management’s holdings in Bristol-Myers Squibb were worth $342,000 as of its […]

Atria Investments Inc boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the 2nd quarter, Holdings Channel reports. The fund owned 160,279 shares of the biopharmaceutical company’s stock after acquiring an additional 7,402 shares during the quarter. Atria Investments Inc’s holdings in Bristol-Myers Squibb were worth $10,246,000 at the […]

BMO Capital Markets cut shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from an outperform rating to a market perform rating in a report released on Friday morning, MarketBeat.com reports. The firm currently has $60.00 price target on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on BMY. SVB Leerink […]

BMO Capital Markets cut shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from an outperform rating to a market perform rating in a research note released on Friday morning, MarketBeat Ratings reports. They currently have $60.00 price target on the biopharmaceutical company’s stock. Other equities analysts have also issued reports about the company. William Blair […]